Related Experiment Video

Updated: May 20, 2026

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Delivery of therapeutic RNA molecules to cancer cells by bacteria

Hermann Lage1, Johannes H Fruehauf

  • 1Charité Campus Mitte, Institute of Pathology, Charitéplatz I, 10117 Berlin, Germany. hermann.lage@charite.de

Therapeutic Delivery
|July 25, 2012
PubMed

Insights

Bacteria can deliver RNA interference (RNAi) therapies to target cells, overcoming a key challenge in RNA-based treatment development. Two novel strategies, transkingdom RNAi (tkRNAi) and bacteria-mediated RNAi (bmRNAi), leverage bacteria for therapeutic RNA delivery.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Therapeutics Development

Background:

  • Effective delivery of RNA-based therapeutics, such as RNA interference (RNAi) effectors, to target cells remains a significant hurdle.
  • Bacteria's known ability to mediate tumor shrinkage presents an opportunity for developing novel therapeutic delivery systems.

Purpose of the Study:

  • To explore the use of nonpathogenic bacteria for producing and delivering therapeutic RNA molecules to target cells for RNAi.
  • To describe two bacteria-based strategies: transkingdom RNAi (tkRNAi) and bacteria-mediated RNAi (bmRNAi).

Main Methods:

  • The tkRNAi concept involves invasive bacteria that produce therapeutic short hairpin RNAs (shRNAs) for delivery into target cells.
  • The bmRNAi technology employs invasive bacteria carrying DNA constructs encoding RNAi effectors, which are transcribed within the target cell by host machinery.

Main Results:

  • Two distinct bacteria-based RNAi delivery strategies, tkRNAi and bmRNAi, have been developed.
  • These methods aim to overcome the challenge of delivering RNAi effectors to target cells using engineered bacteria.

Conclusions:

  • Bacteria-based approaches offer a promising strategy for advancing RNA-based therapies.
  • tkRNAi and bmRNAi represent innovative methods for targeted RNAi delivery, potentially improving therapeutic outcomes.

More Related Videos

Bioluminescent Bacterial Imaging In Vivo05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli08:25

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

Published on: March 20, 2016

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.